Quick Answer
ROCKWELL MEDICAL, INC. reported Total Revenue of $57.30 million for fiscal year 2017.
ROCKWELL MEDICAL, INC. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | — | — | — | — | — | — |
| Net Income | -$5.31M -1007.1% |
-$480.0K +94.3% |
-$8.44M +54.8% |
-$18.68M +42.8% |
-$32.67M -5.8% |
-$30.89M +9.5% |
| Diluted EPS | -$0.15 -400.0% |
-$0.03 +91.9% |
-$0.37 +71.8% |
-$1.31 +65.8% |
-$3.83 -834.1% |
-$0.41 |
| Total Assets | $57.15M -3.5% |
$59.21M +13.5% |
$52.17M +11.9% |
$46.63M -4.0% |
$48.57M -37.5% |
$77.75M +75.4% |
| Cash and Equivalents | $10.71M -31.6% |
$15.66M +74.4% |
$8.98M -11.1% |
$10.10M -23.9% |
$13.28M -72.7% |
$48.68M +312.7% |
| Long-Term Debt | $8.83M +4.2% |
$8.47M +2.2% |
$8.29M +9.8% |
$7.55M -42.7% |
$13.19M -37.1% |
$20.95M |
| Stockholders Equity | $36.98M +13.5% |
$32.59M +53.1% |
$21.29M +50.9% |
$14.11M +456.4% |
$2.54M -92.6% |
$34.17M +68.2% |
| R&D Expense | $0.00 -100.0% |
$19.0K -98.3% |
$1.11M | — | — | — |
| Operating Income | -$4.69M -871.5% |
$608.0K +109.1% |
-$6.67M +60.3% |
-$16.78M +44.7% |
-$30.34M -6.7% |
-$28.42M +17.7% |
| Gross Profit | $11.70M -33.1% |
$17.48M +100.9% |
$8.70M +113.5% |
$4.08M +268.5% |
-$2.42M -188.8% |
$2.73M -4.0% |
| Shares Outstanding | 39.41M +15.7% |
34.06M +16.9% |
29.13M +139.5% |
12.16M +42.4% |
8.54M -90.9% |
93.57M +43.1% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2017 | $14.63M | +14.1% | +10.4% |
| Net Income | September 30, 2025 | -$1.75M | -205.3% | -17.5% |
| Diluted EPS | September 30, 2025 | -$0.05 | -225.0% | +0.0% |
| Total Assets | September 30, 2025 | $57.49M | +0.7% | +9.2% |
| Cash and Equivalents | September 30, 2025 | $13.61M | +10.3% | +9.0% |
| Long-Term Debt | September 30, 2025 | $8.74M | +4.2% | +1.0% |
| Stockholders Equity | September 30, 2025 | $37.02M | +27.1% | +21.7% |
| R&D Expense | September 30, 2025 | $0.00 | — | — |
| Operating Income | September 30, 2025 | -$1.58M | -181.8% | -17.4% |
| Gross Profit | September 30, 2025 | $2.27M | -63.6% | -9.2% |
| Shares Outstanding | September 30, 2025 | 39.41M | +21.9% | +14.4% |
- ROCKWELL MEDICAL, INC. reported Total Revenue of $57.30 million for fiscal year 2017.
- ROCKWELL MEDICAL, INC. showed an increase of +7.5% in Total Revenue compared to the prior fiscal year.
- ROCKWELL MEDICAL, INC. reported Net Income of -$5.31 million for fiscal year 2025.
- ROCKWELL MEDICAL, INC. showed a decrease of -1007.1% in Net Income compared to the prior fiscal year.
- ROCKWELL MEDICAL, INC. reported Diluted EPS of $0.15 per share (loss) for fiscal year 2025.
- ROCKWELL MEDICAL, INC. showed a decrease of -400.0% in Diluted EPS compared to the prior fiscal year.
- ROCKWELL MEDICAL, INC. reported Total Assets of $57.15 million for fiscal year 2025.
- ROCKWELL MEDICAL, INC. showed a decrease of -3.5% in Total Assets compared to the prior fiscal year.
- ROCKWELL MEDICAL, INC. reported Cash and Equivalents of $10.71 million for fiscal year 2025.
- ROCKWELL MEDICAL, INC. showed a decrease of -31.6% in Cash and Equivalents compared to the prior fiscal year.
- ROCKWELL MEDICAL, INC. reported Long-Term Debt of $8.83 million for fiscal year 2025.
- ROCKWELL MEDICAL, INC. showed an increase of +4.2% in Long-Term Debt compared to the prior fiscal year.
- ROCKWELL MEDICAL, INC. reported Stockholders Equity of $36.98 million for fiscal year 2025.
- ROCKWELL MEDICAL, INC. showed an increase of +13.5% in Stockholders Equity compared to the prior fiscal year.
- ROCKWELL MEDICAL, INC. reported R&D Expense of $0.00 for fiscal year 2025.
- ROCKWELL MEDICAL, INC. showed a decrease of -100.0% in R&D Expense compared to the prior fiscal year.
- ROCKWELL MEDICAL, INC. reported Operating Income of -$4.69 million for fiscal year 2025.
- ROCKWELL MEDICAL, INC. showed a decrease of -871.5% in Operating Income compared to the prior fiscal year.
- ROCKWELL MEDICAL, INC. reported Gross Profit of $11.70 million for fiscal year 2025.
- ROCKWELL MEDICAL, INC. showed a decrease of -33.1% in Gross Profit compared to the prior fiscal year.
- ROCKWELL MEDICAL, INC. reported Shares Outstanding of 39.41 million shares for fiscal year 2025.
- ROCKWELL MEDICAL, INC. showed an increase of +15.7% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: